← Open Payments lookup

BROOKE ENDERLE: Open Payments

NPI 1700461290 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,306 in 64 payments from 16 companies in 2025. Trend: 2023 $1,492 · 2024 $1,298 · 2025 $1,306

Food & beverage: $1,306
CompanyPaymentsAmount
Novo Nordisk Inc13$247
Otsuka America Pharmaceutical, Inc.10$161
Indivior Inc.6$141
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$140
ANI Pharmaceuticals, Inc.4$124
Astellas Pharma US Inc3$70
Abbott Laboratories3$68
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$64
Lilly USA, LLC3$62
AstraZeneca Pharmaceuticals LP3$55

Products named: REXULTI, SUBLOCADE, CAPLYTA, PURIFIED CORTROPHIN GEL, Wegovy, Veozah, Rybelsus, FREESTYLE LIBRE 3.

Industry payments across DE — which companies pay providers there.